Spectrum of bacterial keratitis in North India: A retrospective analysis of six years at a tertiary care eye center

被引:8
作者
Ahmed, Nishat H. [1 ,3 ]
Mishra, Deepanshi [1 ]
Rathod, Prachala [1 ]
Satpathy, Gita [1 ]
Titiyal, Jeewan S. [2 ]
Tandon, Radhika [2 ]
Nandyala, Sushma [2 ]
Agarwal, Tushar [2 ]
Vanathi, Murugesan [2 ]
Sinha, Rajesh [2 ]
Gupta, Noopur [2 ]
Maharana, Prafulla K. [2 ]
Kaur, Manpreet [2 ]
Sharma, Namrata [2 ]
机构
[1] All India Inst Med Sci, New Delhi, India
[2] All India Inst Med Sci, Ophthalmol, Dr RP Ctr Ophthalm Sci, New Delhi, India
[3] All India Inst Med Sci, Ocular Microbiol, Dr RP Ctr Ophthalm Sci, New Delhi 110029, India
关键词
Antimicrobial susceptibility testing; bacterial keratitis; bacterial pathogens; empirical antibiotics; seasonal variation; INFECTIOUS KERATITIS; MICROBIAL KERATITIS; EPIDEMIOLOGIC FEATURES; FUNGAL KERATITIS; 12-YEAR ANALYSIS; RISK-FACTORS; TRENDS; SUSCEPTIBILITY; PROFILE; EXPERIENCE;
D O I
10.4103/ijo.IJO_2915_21
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To analyze the pattern of bacterial pathogens causing infective keratitis and their resistance to the recommended antibiotics over six years. Methods: It was a retrospective study of 9,357 cases of bacterial keratitis from January 2015 to December 2020, at a tertiary care ophthalmic center. A total of 9,547 corneal specimens were obtained from the study subjects. Demographic details of the patients, pathogenic bacteria isolated, and their antimicrobial susceptibility were noted and analyzed. Results: Bacterial pathogens were identified in 23.52% of the specimens. The most common isolates were coagulase-negative Staphylococci (60.75%), followed by Pseudomonas aeruginosa (14.23%), Staphylococcus aureus (13.92%), gram negative bacilli of the family Enterobacterales (8.64%), Streptococcus spp. (1.72%), Acinetobacter spp. (0.13%), and other non-fermenting gram-negative bacilli (0.57%). In Staphylococci, 55-80% of isolates were resistant to erythromycin, and 40-70% to fluoroquinolones, while no resistance was observed against vancomycin. 40-60% of isolates of P. aeruginosa were resistant to cephalosporins, 40-55% to fluoroquinolones, and 30-60% to aminoglycosides. Also, 40-80% of isolates of Enterobacterales were resistant to cephalosporins, and 50-60% to fluoroquinolones. Most gram-negative isolates were susceptible to carbapenems and polymyxin B. Conclusion: To the best of our knowledge, our study is the largest compilation of microbiological profile of bacterial keratitis from North India. It highlights the current trend of the bacterial pathogens that cause infectious keratitis. Staphylococci and Pseudomonas were found to be the most common pathogens. Increased resistance was seen against some of the commonly prescribed empirical antibiotics. Such evidence is useful for restructuring the empirical prescription practices from time to time.
引用
收藏
页码:1982 / 1989
页数:8
相关论文
共 34 条
[1]   Delhi infectious keratitis study: Update on clinico-Microbiological profile and outcomes of infectious keratitis [J].
Acharya, Manisha ;
Farooqui, Javed Hussain ;
Gaba, Tanuj ;
Gandhi, Arpan ;
Mathur, Umang .
JOURNAL OF CURRENT OPHTHALMOLOGY, 2020, 32 (03) :249-255
[2]  
Al-Mujaini Abdullah, 2009, Sultan Qaboos Univ Med J, V9, P184
[3]  
Arya SK, 2004, N ZONE OPHTHALMIC SO, V14
[4]  
Attri SD., 2010, CLIMATE PROFILE INDI
[5]  
Baca-Lozada O, 2013, COMMON EYE INFECT
[6]  
Basak Samar K., 2005, Indian Journal of Ophthalmology, V53, P17
[7]   Microbial keratitis in South India: Influence of risk factors, climate, and geographical variation [J].
Bharathi, M. Jayahar ;
Ramakrishnan, R. ;
Meenakshi, R. ;
Padmavathy, S. ;
Shivakumar, C. ;
Srinivasan, M. .
OPHTHALMIC EPIDEMIOLOGY, 2007, 14 (02) :61-69
[8]  
Clinical and Laboratorial Standards Institute (CLSI), 2015, Standard for Quality in Your Laboratory with CLSI
[9]  
Deorukhkar S, 2012, SINGAP MED J, V53, P264
[10]   Geographic Disparities in the Etiology of Bacterial and Fungal Keratitis in the United States of America [J].
Estopinal, Christopher B. ;
Ewald, Mark D. .
SEMINARS IN OPHTHALMOLOGY, 2016, 31 (04) :345-352